Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Assets (2021 - 2025)

Krystal Biotech's Return on Assets history spans 5 years, with the latest figure at 0.16% for Q4 2025.

  • For Q4 2025, Return on Assets rose 7.0% year-over-year to 0.16%; the TTM value through Dec 2025 reached 0.16%, up 7.0%, while the annual FY2025 figure was 0.17%, 8.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.16% at Krystal Biotech, down from 0.17% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.17% in Q3 2025 and bottomed at 0.25% in Q1 2023.
  • The 5-year median for Return on Assets is 0.01% (2023), against an average of 0.03%.
  • The largest annual shift saw Return on Assets dropped -12bps in 2022 before it surged 35bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.13% in 2021, then tumbled by -91bps to 0.25% in 2022, then soared by 106bps to 0.01% in 2023, then surged by 544bps to 0.09% in 2024, then soared by 82bps to 0.16% in 2025.
  • Per Business Quant, the three most recent readings for KRYS's Return on Assets are 0.16% (Q4 2025), 0.17% (Q3 2025), and 0.13% (Q2 2025).